{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:42:44Z","timestamp":1793320964389,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.clindermatol.2026.04.009","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T16:24:04Z","timestamp":1775579044000},"page":"415-425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Topical vitamins: Uses and limitations\u2014part I"],"prefix":"10.1016","volume":"44","author":[{"given":"Partha","family":"Mukhopadhyay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujata","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Shafeeqe","family":"P","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2026.04.009_bib0001","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2174\/1389557054553820","article-title":"Retinoids as therapeutic agents: today and tomorrow","volume":"5","author":"Vivat-Hannah","year":"2005","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0002","series-title":"Comprehensive Dermatologic Drug Therapy","first-page":"528","article-title":"Topical retinoids","author":"Sami","year":"2021"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0003","doi-asserted-by":"crossref","first-page":"742","DOI":"10.25259\/IJDVL_741_20","article-title":"Trifarotene \u2013 the latest retinoid","volume":"87","author":"Santhosh","year":"2021","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0004","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/14728214.2021.1887138","article-title":"Emerging topical drugs for the treatment of rosacea","volume":"26","author":"Dall'Oglio","year":"2021","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0005","series-title":"Retinoids in Dermatology","first-page":"125","article-title":"Retinoids in rosacea","author":"Rademaker","year":"2019"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0006","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4103\/0019-5154.77550","article-title":"Evaluation of topical 0.1% tazarotene cream in the treatment of palmoplantar psoriasis: an observer-blinded randomized controlled study","volume":"56","author":"Mehta","year":"2011","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0007","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ad.2012.04.008","article-title":"Nail psoriasis: treatment with tazarotene 0.1% hydrophilic ointment","volume":"103","author":"Fischer-Levancini","year":"2012","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0008","series-title":"Retinoids in Dermatology","first-page":"135","article-title":"Retinoids in psoriasis","author":"Wollina","year":"2019"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0009","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000346750","article-title":"Topical retinoids in oral lichen planus treatment: an overview","volume":"226","author":"Petruzzi","year":"2013","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0010","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1525-1470.2007.00603.x","article-title":"Response of juvenile circumscribed pityriasis rubra pilaris to topical tazarotene treatment","volume":"25","author":"Karimian-Teherani","year":"2008","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0011","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/pde.14408","article-title":"Consensus recommendations for the use of retinoids in ichthyosis and other disorders of cornification in children and adolescents","volume":"38","author":"Zaenglein","year":"2021","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0012","series-title":"Retinoids in Dermatology","first-page":"145","article-title":"Retinoids in keratinization disorders","author":"T\u00fcrsen","year":"2019"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0013","series-title":"Retinoids in Dermatology","first-page":"157","article-title":"Retinoids in antiaging therapy","author":"Serdar","year":"2019"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0014","series-title":"Cosmetic Dermatology: Products and Procedures","first-page":"336","article-title":"Topical vitamins","author":"Bisset","year":"2016"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0015","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1080\/09546634.2017.1309349","article-title":"Retinoids: a journey from the molecular structures and mechanisms of action to clinical uses in dermatology and adverse effects","volume":"28","author":"Khalil","year":"2017","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0016","series-title":"Retinoids in Dermatology","first-page":"171","article-title":"Retinoids in lymphoma","author":"Duffy","year":"2019"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0017","series-title":"Retinoids in Dermatology","first-page":"177","article-title":"Retinoids in cutaneous chemoprophylaxis","author":"Duffy","year":"2019"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0018","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012622","article-title":"The use of retinoids for the prevention and treatment of skin cancers: an updated review","volume":"23","author":"Ramchatesingh","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0019","series-title":"Retinoids in Dermatology","first-page":"129","article-title":"Retinoids in hair disorders","author":"Doolan","year":"2019"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0020","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2165\/00128071-200708050-00003","article-title":"Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial","volume":"8","author":"Shin","year":"2007","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0021","doi-asserted-by":"crossref","first-page":"592.e1","DOI":"10.1016\/j.jaad.2009.02.037","article-title":"Phase I\/II randomized bilateral half-head comparison of topical bexarotene 1% gel for alopecia areata","volume":"61","author":"Talpur","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0022","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4103\/0019-5154.62747","article-title":"Comparative assessment of topical steroids, topical tretinoin (0.05%) and dithranol paste in alopecia areata","volume":"55","author":"Das","year":"2010","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0023","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12574","article-title":"Use of adapalene in alopecia areata: efficacy and safety of mometasone furoate 0.1% cream versus combination of mometasone furoate 0.1% cream and adapalene 0.1% gel in alopecia areata","volume":"31","author":"Unal","year":"2018","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0024","series-title":"Retinoids in Dermatology","first-page":"163","article-title":"Retinoids in other skin diseases","author":"Wollina","year":"2019"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0025","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1046\/j.1365-2133.2003.05729.x","article-title":"Novel treatment of chronic severe hand dermatitis with bexarotene gel","volume":"150","author":"Hanifin","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0026","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2013-1728","article-title":"Milia en plaque of the nose: report of a case and successful treatment with topical tretinoin","volume":"133","author":"Nambudiri","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0027","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/j.1468-3083.2006.02063.x","article-title":"Tazarotene-induced irritation causing vitiligo by Koebnerization","volume":"21","author":"Narang","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0028","series-title":"Comprehensive Dermatologic Drug Therapy","first-page":"557","article-title":"Topical vitamin D3","author":"Helfrich","year":"2021"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0029","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jcb.10329","article-title":"Analogs of 1alpha,25-dihydroxyvitamin D3 as pluripotent immunomodulators","volume":"88","author":"Van Etten","year":"2003","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0030","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.3390\/cells12192387","article-title":"Using a topical formulation of vitamin D for the treatment of vitiligo: a systematic review","volume":"12","author":"Al-Smadi","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0031","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2147\/TCRM.S1478","article-title":"Calcipotriol\/betamethasone dipropionate in the treatment of psoriasis vulgaris","volume":"4","author":"Vakirlis","year":"2008","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0032","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-2133.1994.tb13121.x","article-title":"Topical treatment of pityriasis rubra pilaris with calcipotriol","volume":"130","author":"Van de Kerkhof","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0033","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1468-3083.2006.01420.x","article-title":"Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo","volume":"20","author":"Kumaran","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0034","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/jocd.15621","article-title":"Efficacy of topical vitamin D combined with microneedling in the treatment of vitiligo: a comparative study","volume":"22","author":"Salem","year":"2023","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0035","doi-asserted-by":"crossref","first-page":"344","DOI":"10.4103\/0378-6323.159928","article-title":"Vitamin D and skin diseases: a review","volume":"81","author":"Wadhwa","year":"2015","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0036","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2310\/7750.2013.13109","article-title":"Off-label uses of topical vitamin D in dermatology: a systematic review","volume":"18","author":"Wat","year":"2014","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0037","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1001\/archderm.1995.01690170058008","article-title":"Efficacy, tolerability, and safety of calcipotriol ointment in disorders of keratinization. Results of a randomized, double-blind, vehicle-controlled, right\/left comparative study","volume":"131","author":"Kragballe","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0038","first-page":"33","article-title":"Successful treatment of Grover's disease with calcipotriol","volume":"8","author":"Mota","year":"1998","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0039","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/j.1365-2133.1995.tb00740.x","article-title":"Treatment of Grover\u2019s disease with calcipotriol","volume":"132","author":"Keohane","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0040","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1046\/j.1365-2230.2002.09771.x","article-title":"Treatment of Grover's disease with tacalcitol","volume":"27","author":"Hayashi","year":"2002","journal-title":"Clin Exp Dermatol"},{"issue":"suppl 2","key":"10.1016\/j.clindermatol.2026.04.009_bib0041","first-page":"81","article-title":"Grover's disease: successful treatment with acitretin and calcipotriol","volume":"116","author":"Miljkovi\u0107","year":"2004","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0042","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1046\/j.1365-2133.1998.02522.x","article-title":"1alpha,24-dihydroxyvitamin D3 (tacalcitol) is effective against Hailey-Hailey disease both in vivo and in vitro","volume":"139","author":"Aoki","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0043","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1365-2133.2005.06489.x","article-title":"Hailey\u2013Hailey disease responsive to topical calcitriol","volume":"152","author":"Rajpara","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0044","doi-asserted-by":"crossref","first-page":"389","DOI":"10.5021\/ad.2013.25.3.389","article-title":"Hailey-Hailey disease treated with topical tacalcitol","volume":"25","author":"Jeon","year":"2013","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0045","doi-asserted-by":"crossref","first-page":"60","DOI":"10.36849\/JDD.6632","article-title":"Use of topical calcipotriol plus 5-fluorouracil in the treatment of actinic keratosis: a systematic review","volume":"21","author":"Mohney","year":"2022","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0046","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/ced.14603","article-title":"Inflammatory linear verrucous epidermal naevus successfully treated with a combination of triple topical agents (corticosteroid, calcipotriol and 20% urea","volume":"46","author":"Hong","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0047","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2133.1996.tb01153.x","article-title":"Topical vitamin D3 (tacalcitol) for steroid-resistant prurigo","volume":"135","author":"Katayama","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0048","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1080\/09546634.2021.1959014","article-title":"Pityriasis alba: toward an effective treatment","volume":"33","author":"Abdel-Wahab","year":"2022","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0049","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1365-2133.2003.05766.x","article-title":"Topical vitamin D3 derivatives for recalcitrant warts in three immunocompromised patients","volume":"150","author":"Egawa","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0050","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1346-8138.2007.00266.x","article-title":"Successful treatment of refractory warts with topical vitamin D3 derivative (maxacalcitol, 1\u03b1, 25-dihydroxy-22-oxacalcitriol) in 17 patients","volume":"34","author":"Imagawa","year":"2007","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0051","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1001\/jamadermatol.2022.0154","article-title":"Treatment of verruca plana with topical combination of calcipotriol and fluorouracil","volume":"158","author":"Berumen-Glinz","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0052","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.1365-4362.1999.00714.x","article-title":"Calcipotriol ointment vs. betamethasone 17-valerate ointment in the treatment of lichen amyloidosis","volume":"38","author":"Khoo","year":"1999","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0053","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.3390\/pharmaceutics14112479","article-title":"Tocotrienol in the treatment of topical wounds: recent updates","volume":"14","author":"Nair","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0054","doi-asserted-by":"crossref","first-page":"311","DOI":"10.4103\/2229-5178.185494","article-title":"Vitamin E in dermatology","volume":"7","author":"Keen","year":"2016","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0055","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.mam.2007.06.001","article-title":"Vitamin E in human skin: organ-specific physiology and considerations for its use in dermatology","volume":"28","author":"Thiele","year":"2007","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0056","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1524-4725.2005.31724","article-title":"Ekanayake-Mudiyanselage S. Vitamin E: critical review of its current use in cosmetic and clinical dermatology","volume":"31","author":"Thiele","year":"2005","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0057","first-page":"1467","article-title":"Evaluation of efficacy and tolerance of a nighttime topical antioxidant containing resveratrol, baicalin, and vitamin E for treatment of mild to moderately photodamaged skin","volume":"13","author":"Farris","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0058","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1365-4362.1995.tb00628.x","article-title":"Vitamin E added silicone gel sheets for treatment of hypertrophic scars and keloids","volume":"34","author":"Palmieri","year":"1995","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0059","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/09546639809160549","article-title":"Successful treatment of granuloma annulare with a topically applied vitamin E emulsion: a retrospective study","volume":"9","author":"Bogenrieder","year":"1998","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0060","first-page":"190","article-title":"Acute radiation dermatitis in breast cancer: topical therapy with vitamin E acetate in lipophilic gel base","volume":"4","author":"Martella","year":"2010","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejon.2022.102230","article-title":"Topical application of a cream containing nanoparticles with vitamin E for radiodermatitis prevention in women with breast cancer: a randomized, triple-blind, controlled pilot trial","volume":"61","author":"Queiroz Schmidt","year":"2022","journal-title":"Eur J Oncol Nurs"},{"issue":"3 Suppl 54","key":"10.1016\/j.clindermatol.2026.04.009_bib0062","first-page":"51","article-title":"Vitamin E gel reduces time of healing of digital ulcers in systemic sclerosis","volume":"27","author":"Fiori","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0063","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/ijd.15133","article-title":"Treatment of melasma: a review of less commonly used antioxidants","volume":"60","author":"Babbush","year":"2021","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0064","series-title":"Comprehensive Dermatologic Drug Therapy","first-page":"624","article-title":"Miscellaneous topical agents","author":"Roy","year":"2021"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0065","first-page":"127","article-title":"Treatment of a periorbital hyperpigmentation with topical vitamin K\/vitamin A","volume":"12","author":"Elson","year":"1999","journal-title":"Cosmet Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0066","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1067\/mjd.2002.120465","article-title":"The effects of topical vitamin K on bruising after laser treatment","volume":"47","author":"Shah","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0067","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.5958\/0974-360X.2020.00687.3","article-title":"The effectiveness of topical vitamin K cream 1% in the treatment of steroid-induced rosacea","volume":"13","author":"Abdullah","year":"2020","journal-title":"Res J Pharm Technol"},{"key":"10.1016\/j.clindermatol.2026.04.009_bib0068","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.3390\/ijms20102548","article-title":"Prodrugs for skin delivery menahydroquinone-4, an active form of vitamin K2(20), could overcome the photoinstability and phototoxicity of vitamin K2(20)","volume":"20","author":"Goto","year":"2019","journal-title":"Int J Mol Sci"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X26000957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X26000957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T07:20:02Z","timestamp":1780039202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X26000957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0738081X26000957"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2026.04.009","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical vitamins: Uses and limitations\u2014part I","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2026.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}